BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
BRAF
,
Angiogenesis
,
Arthritis
,
Neuron
,
Biofuel
,
Phenobarbital
,
rs4950928
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SYK protein
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Ovarian carcinoma OVISE cells with wildtype or SYK knockout treated with EGF
Loss of Syk in MCF10A cells
Explore Curated Studies Results
Literature
Most Relevant Literature
Review and prospects of targeted therapies for Spleen tyrosine kinase (SYK).
Identification of natural product-based effective inhibitors of spleen tyrosine kinase (SYK) through…
The ubiquitous role of spleen tyrosine kinase (Syk) in gut diseases: From mucosal immunity to target…
Discovery and optimization of 4-pyrazolyl-2-aminopyrimidine derivatives as potent spleen tyrosine ki…
Microglia are SYK of Aβ and cell debris.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes
Imatinib's Effect on the Suppression of Malaria Parasites in Patients With Uncomplicated Plasmodium …
A Pilot Study of Sorafenib Examining Biomarkers in Refractory or Relapsed T-Cell Lymphoma Patients
Erlotinib Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Pacritinib and Chemotherapy in Treating Patients With Acute Myeloid Leukemia and FLT3 Mutations
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ